Endurance training modulates intramyocellular lipid compartmentalization and morphology in skeletal muscle of lean and obese women

Journal of Clinical Endocrinology and Metabolism

Volumn 98, Issue 12, 2013, Pages 4852-4862

  Devries, Michaela C ^a   Samjoo, Imtiaz A ^a   Hamadeh, Mazen J ^a,b   McCready, Colin ^a   Raha, Sandeep ^a   Watt, Matthew J ^a,c   Steinberg, Gregory R ^a   Tarnopolsky, Mark A ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b YORK UNIVERSITY   (Canada)

^c MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CERAMIDE; CHOLESTEROL; DIACYLGLYCEROL; FATTY ACID; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; INTRAMYOCELLULAR LIPID; LACTIC ACID; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD SAMPLING; CELL ULTRASTRUCTURE; CLINICAL ARTICLE; CONTROLLED STUDY; ENDURANCE TRAINING; FATTY ACID OXIDATION; FEMALE; HUMAN; HUMAN TISSUE; INSULIN RESISTANCE; LEAN BODY WEIGHT; LIPID BLOOD LEVEL; LIPID METABOLISM; LIPID OXIDATION; LIPID STORAGE; MIDDLE AGED; MITOCHONDRIAL RESPIRATION; MUSCLE BIOPSY; MUSCLE LEVEL; OBESITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SARCOLEMMA; SEDENTARY LIFESTYLE; SKELETAL MUSCLE; VASTUS LATERALIS MUSCLE; WEIGHT CHANGE; YOUNG ADULT;

ADULT; BICYCLING; BIOLOGICAL MARKERS; BODY MASS INDEX; CERAMIDES; DIGLYCERIDES; EXERCISE; FEMALE; HUMANS; INSULIN RESISTANCE; LIPID METABOLISM; MIDDLE AGED; MITOCHONDRIA, MUSCLE; MITOCHONDRIAL TURNOVER; MUSCLE, SKELETAL; OBESITY; OXIDATIVE PHOSPHORYLATION; PHYSICAL ENDURANCE; QUADRICEPS MUSCLE; SARCOPLASMIC RETICULUM; THINNESS; YOUNG ADULT;

EID: 84889797049     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2013-2044     Document Type: Article

References (44)

1. GoodpasterBH,Theriault R, Watkins SC, Kelley DE. Intramuscular lipid content is increased in obesity and decreased by weight loss. Metabolism. 2000;49:467-472.
2. Hulver MW, Berggren JR, Cortright RN, et al. Skeletal muscle lipid metabolism with obesity. Am J Physiol Endocrinol Metab. 2003; 284:E741-E747.
3. Kelley DE, Goodpaster B, Wing RR, Simoneau JA. Skeletal muscle fatty acid metabolism in association with insulin resistance, obesity, and weight loss. Am J Physiol. 1999;277:E1130-E1141.
4. Goodpaster BH, Thaete FL, Simoneau JA, Kelley DE. Subcutaneous abdominal fat and thigh muscle composition predict insulin sensitivity independently of visceral fat. Diabetes. 1997;46:1579-1585.
5. Kelley DE, He J, Menshikova EV, Ritov VB. Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. Diabetes. 2002;51:2944-2950.
6. Petersen KF, Dufour S, Befroy D, Garcia R, Shulman GI. Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N Engl J Med. 2004;350:664-671.
7. Goodpaster BH, He J, Watkins S, Kelley DE. Skeletal muscle lipid content and insulin resistance: Evidence for a paradox in endurancetrained athletes. J Clin Endocrinol Metab. 2001;86:5755-5761.
8. van Loon LJ, Koopman R, Manders R, van der Weegen W, van Kranenburg GP, Keizer HA. Intramyocellular lipid content in type 2 diabetes patients compared with overweight sedentary men and highly trained endurance athletes. Am J Physiol Endocrinol Metab. 2004;287:E558-E565.
9. Lee JS, Pinnamaneni SK, Eo SJ, et al. Saturated, but not n-6 polyunsaturated, fatty acids induce insulin resistance: Role of intramuscular accumulation of lipid metabolites. J Appl Physiol. 2006;100: 1467-1474.
10. Pickersgill L, Litherland GJ, Greenberg AS, Walker M, Yeaman SJ. Key role for ceramides in mediating insulin resistance in human muscle cells. J Biol Chem. 2007;282:12583-12589.
11. He J, Goodpaster BH, Kelley DE. Effects of weight loss and physical activity on muscle lipid content and droplet size. Obes Res. 2004; 12:761-769.
12. Phillips SM, Stewart BG, Mahoney DJ, et al. Body-weight-support treadmill training improves blood glucose regulation in persons with incomplete spinal cord injury. J Appl Physiol. 2004;97:716-724.
13. Phillips SM, Han XX, Green HJ, Bonen A. Increments in skeletal muscle GLUT-1 and GLUT-4 after endurance training in humans. Am J Physiol. 1996;270:E456-E462.
14. Pruchnic R, Katsiaras A, He J, Kelley DE, Winters C, Goodpaster BH. Exercise training increases intramyocellular lipid and oxidative capacity in older adults. Am J Physiol Endocrinol Metab. 2004; 287:E857-E862.
15. Tarnopolsky MA, Rennie CD, Robertshaw HA, Fedak-Tarnopolsky SN, Devries MC, Hamadeh MJ. Influence of endurance exercise training and sex on intramyocellular lipid and mitochondrial ultrastructure, substrate use, and mitochondrial enzyme activity. Am J Physiol Regul Integr Comp Physiol. 2007;292: R1271-R1278.
16. Phillips SM, Green HJ, Tarnopolsky MA, Heigenhauser GF, Hill RE, Grant SM. Effects of training duration on substrate turnover and oxidation during exercise. J Appl Physiol. 1996;81:2182-2191.
17. Devries MC, Lowther SA, Glover AW, Hamadeh MJ, Tarnopolsky MA. IMCL area density, but not IMCL utilization, is higher in women during moderate-intensity endurance exercise, compared with men. Am J Physiol Regul Integr Comp Physiol. 2007;293: R2336-R2342.
18. Carter SL, Rennie C, Tarnopolsky MA. Substrate utilization during endurance exercise in men and women after endurance training. Am J Physiol Endocrinol Metab. 2001;280:E898-E907.
19. Péronnet F, Massicotte D. Table of nonprotein respiratory quotient: An update. Can J Sport Sci. 1991;16:23-29.
20. Emoto M, Nishizawa Y, Maekawa K, et al. Homeostasis model assessment as a clinical index of insulin resistance in type 2 diabetic patients treated with sulfonylureas. Diabetes Care. 1999;22:818- 822.
21. Lowry O, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193:265- 275.
22. Carter SL, Rennie CD, Hamilton SJ, Tarnopolsky MA. Changes in skeletal muscle in males and females following endurance training. Can J Physiol Pharmacol. 2001;79:386-392.
23. Watt MJ, Dzamko N, Thomas WG, et al. CNTF reverses obesityinduced insulin resistance by activating skeletal muscle AMPK. Nat Med. 2006;12:541-548.
24. Lee CD, Blair SN, Jackson AS. Cardiorespiratory fitness, body composition, and all-cause and cardiovascular disease mortality in men. Am J Clin Nutr. 1999;69:373-380.
25. Stevens J, Evenson KR, Thomas O, Cai J, Thomas R. Associations of fitness and fatness with mortality in Russian and American men in the lipids research clinics study. Int J Obes Relat Metab Disord. 2004;28:1463-1470.
26. Wessel TR, Arant CB, Olson MB, et al. Relationship of physical fitness vs body mass index with coronary artery disease and cardiovascular events in women. JAMA. 2004;292:1179-1187.
27. Li TY, Rana JS, Manson JE, et al. Obesity as compared with physical activity in predicting risk of coronary heart disease in women. Circulation. 2006;113:499-506.
28. Weinstein AR, Sesso HD, Lee IM, et al. Relationship of physical activity vs body mass index with type 2 diabetes in women. JAMA. 2004;292:1188-1194.
29. Hu G, Tuomilehto J, Silventoinen K, Barengo N, Jousilahti P. Joint effects of physical activity, body mass index, waist circumference and waist-to-hip ratio with the risk of cardiovascular disease among middle-aged Finnish men and women. Eur Heart J. 2004;25:2212- 2219.
30. Kavouras SA, Panagiotakos DB, Pitsavos C, et al. Physical activity, obesity status, and glycemic control: The ATTICA Study. Med Sci Sports Exerc. 2007;39:606-611.
31. Hu G, Tuomilehto J, Silventoinen K, Barengo NC, Peltonen M, Jousilahti P. The effects of physical activity and body mass index on cardiovascular, cancer and all-cause mortality among 47 212 middle- aged Finnish men and women. Int J Obes (Lond). 2005;29:894- 902.
32. Storlien L, Oakes ND, Kelley DE. Metabolic flexibility. Proc Nutr Soc. 2004;63:363-368.
33. Ezell DM, Geiselman PJ, Anderson AM, et al. Substrate oxidation and availability during acute exercise in non-obese, obese, and postobese sedentary females. Int J Obes Relat Metab Disord. 1999;23: 1047-1056.
34. Helge JW, FraserAM,KriketosAD,et al. Interrelationships between muscle fibre type, substrate oxidation and body fat. Int J Obes Relat Metab Disord. 1999;23:986-991.
35. Thyfault JP, Kraus RM, Hickner RC, Howell AW, Wolfe RR, Dohm GL. Impaired plasma fatty acid oxidation in extremely obese women. Am J Physiol Endocrinol Metab. 2004;287: E1076-E1081.
36. Goodpaster BH, Wolfe RR, Kelley DE. Effects of obesity on substrate utilization during exercise. Obes Res. 2002;10:575-584.
37. Horowitz JF, Klein S. Oxidation of nonplasma fatty acids during exercise is increased in women with abdominal obesity. J Appl Physiol. 2000;89:2276-2282.
38. Ahlborg G, Felig P, Hagenfeldt L, Hendler R, Wahren J. Substrate turnover during prolonged exercise in man. Splanchnic and leg metabolism of glucose, free fatty acids, and amino acids. J Clin Invest. 1974;53:1080-1090.
39. Owen OE, Felig P, Morgan AP, Wahren J, Cahill GF Jr. Liver and kidney metabolism during prolonged starvation. J Clin Invest. 1969; 48:574-583.
40. Bruce CR, Thrush AB, Mertz VA, et al. Endurance training in obese humans improves glucose tolerance and mitochondrial fatty acid oxidation and alters muscle lipid content. Am J Physiol Endocrinol Metab. 2006;291:E99-E107.
41. Summers SA, Garza LA, Zhou H, Birnbaum MJ. Regulation of insulin-stimulated glucose transporter GLUT4 translocation and Akt kinase activity by ceramide. Mol Cell Biol. 1998;18:5457- 5464.
42. Yu C, Chen Y, Cline G, et al. Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle. J Biol Chem. 2002; 277:50230-50236.
43. Horowitz J. Exercise-induced alterations in muscle lipid metabolism improve insulin sensitivity. Exerc Sport Sci Rev. 2007;35: 192-196.
44. Ritov VB, Menshikova EV, He J, Ferrell RE, Goodpaster BH, Kelley DE. Deficiency of subsarcolemmal mitochondria in obesity and type 2 diabetes. Diabetes. 2005;54:8-14.